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Heterotaxy syndrome is characterized by a wide variety of cardiac and extra-
cardiac congenital malformations that are primarily induced by disorders of the
left-right axis determination during early embryonic development. Prognosis of
the disease remains unsatisfactory because the syndrome is often associated with
complicated congenital heart diseases. Long-term follow-up of heterotaxy
patients, particularly those who underwent Fontan procedure, is now one of
the most important issues in pediatric and adult congenital heart disease clinics.
Collaborative studies between pediatric cardiologists and basic scientists are
essential for improving the prognosis of heterotaxy syndrome.
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6.1 Introduction
Heterotaxy syndrome is a rare but serious congenital disease that occurs approxi-
mately 1 to 5,000–7,000 of live birth [1]. Patients are generally subdivided into
“bilateral right sided” (right isomerism) or “bilateral left sided” (left isomerism)
according to the characteristic morphology of atrial appendages of the heart.
However, there is a wide spectrum of pathology with considerable overlap of the
anatomical features.
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6.2 Molecular and Cellular Mechanisms of Left-Right
Determination
The left-right axis determination initiates in the primitive node at E7.5 in mice and
develops through the following pathways [2, 3]:
1. Breaking of symmetry as a result of leftward “nodal flow”
2. Transmission of asymmetric signals to the lateral plate mesoderm (LMP)
3. Asymmetric expression of nodal and lefty2 in the LMP
4. Situs-specific morphogenesis mediated by asymmetric expression of Pitx2
6.2.1 Node Cell Monocilia Create Leftward “Nodal Flow”
and Activate Asymmetry Signaling Around the Node
The determination of the left-right asymmetry starts as leftward nodal flow
generated by rotational movement of monocilia in the primitive node [4, 5]. Clock-
wise rotation of motile cilia creates unidirectional leftward flow because the
rotational axes of cilia tilt caudal direction of the embryos [6, 7].
There are two models why nodal flow is perceived by nodal and perinodal cells.
One hypothesis (chemosensory model) is that the nodal flow produces a gradient of
left determinant particles (node vesicular parcels) containing hedgehog proteins
and nodal [8, 9], which activate downstream signaling of nodal in the left-side
perinodal cells.
Alternative hypothesis (mechanosensory model) is that the leftward nodal flow
provokes an asymmetrical increase influx of Ca2þ ion in the sensory cilia cells
through PKD2, a causative gene for human polycystic kidney disease [9, 10]. This
Ca2þ influx is linked to the activation of nodal in the left-side perinodal cells, which
is consequently transferred to the left LPM.
6.2.2 Asymmetry Signaling Transmits to the Left Lateral Plate
Mesoderm
Transmission of nodal to the left LMP followed by lefty2 and Pitx2 activation [11]
and the consequent heart morphogenesis in the normal subjects, right/left isomer-
ism, and situs inversus is summarized in Fig. 6.1a.
6.2.3 Genes Associated with the Human Heterotaxy Syndrome
Recent human and animal model studies have provided insights into the genetic and
developmental etiology of the heterotaxy syndrome. In human, genes that are
associated with heterotaxy syndrome are ZIC3, NODAL, CFC1, ACVR2B,
LEFTY2, CITED2, and GDF1 [12–14].
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6.3 Clinical Manifestation of the Heterotaxy Syndrome
Factors that deteriorate prognosis of the heterotaxy syndrome are complications
with pulmonary venous obstruction, pulmonary arterial distortion, regurgitation of
atrioventricular valve, elevated pulmonary vascular resistance, and impaired ven-
tricular function [15].
6.3.1 Right Isomerism
Neonates with right isomerism typically show single atrium, single right ventricle,
and univentricular atrioventricular connection often associated with atrioventricu-
lar valve regurgitation. First-stage palliation (2–4 weeks after birth) is a control of
pulmonary blood flow with pulmonary banding or systemic-pulmonary shunt.
Pulmonary venous obstruction due to total anomalous pulmonary venous drainage
should be precisely diagnosed and repaired by surgical operation.
The second-stage palliation is the bidirectional Glenn shunt, where the right
and/or left superior vena cava is isolated and is connected to the pulmonary artery.
This operation is, in general, performed around 6 months after birth.
The third-stage palliation is Fontan procedure. Recently, a modification using
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Fig. 6.1 Signal transmission of nodal to the left lateral plate mesoderm followed by Pitx2
activation and the consequent heart morphogenesis in normal and heterotaxy embryos (Adapted
and modified from Ref. [1] with permission)
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most often employed, because the long-term prognosis of the conventional atrio-
pulmonary connection is proved to be unsatisfactory characterized by enlargement
of the atrium, intractable atrial tachyarrhythmias, and thromboembolisms.
After successful completion of the TCPC, cyanosis disappears and the general
conditions of the patients improve. However, number of patients who underwent
successful Fontan procedure is approximately 50 % because right isomerism often
accompanied with combination of severe and complicated congenital heart
diseases [16].
6.3.2 Left Isomerism
Left isomerism is typically associated with atrioventricular septal defect, persistent
left superior vena cava, interrupted hepatic portion of the inferior vena cava, and
atrioventricular conduction disturbance. In left isomerism, sinus node and atrioven-
tricular nodes are usually hypoplastic, and sinus bradycardia or complete atrioven-
tricular block is frequently accompanied.
6.4 Long-Term Prognosis of Heterotaxy Patients
Although the medical and surgical treatments of the heterotaxy syndrome have
remarkably advanced, long-term prognosis of the patients remains unsatisfactory.
Right isomerism has been recognized as one of the worst forms of CHD with
overall 5-year survival ranging from 30 to 74 %. The results are better in left
isomerism with 5-year survival rates ranging between 65 and 84 %, which is still
considerably lower than survival for most other forms of CHD [17]. The main
reason is that the nature of the Fontan single ventricle physiology is fundamentally
imperfect. Representative long-term complications of the Fontan operation are
illustrated in Fig. 6.2.
6.4.1 Protein-Losing Enteropathy
Protein-losing enteropathy (PLE), one of the most severe manifestations of the
failing Fontan circulation, occurs in 5–10 % of the total postoperative cases
[15]. Chronic loss of serum proteins into the gastrointestinal tracts results in
systemic edema, ascites, pleural effusion, diarrhea, gastrointestinal bleeding, sus-
ceptibility to infections, and ultimately cachexia. The underlying mechanism of
PLE remains uncertain. Elevated inflammatory reactions such as TNF-α or IFN-α,
dilatation of intestinal lymphatic vessels, and widening between intestinal epithelial
cells may be involved in the protein and fluid losses [18]. Steroids, high molecular
weight heparin, sildenafil, surgical interventions, for instance, fenestration of atrial-
level communications or conversion of the Fontan circuit, are effective. To date,
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Fig. 6.2 Possible complications of mid- to long term after completion of Fontan procedure for
heterotaxy patients (Adapted and modified from Ref. [1] with permission)
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6.4.2 Arrhythmias
Reentrant atrial tachyarrhythmias are the commonest in patients after Fontan
procedure and are often associated with deterioration of hemodynamics, either
causally or as a result [15]. Hemodynamic abnormalities such as valve regurgitation
or outflow obstruction, if present, should be aggressively treated by surgery.
6.4.3 Heart Failure
Initial feature of heart failure long after the Fontan procedure is characterized by
worsening of ventricular relaxation and compliance [15]. These abnormalities may
be caused by exposure of hypoxia and volume/pressure overload preceding the
Fontan procedure, repetitive surgical operations, and hemodynamic disadvantages
of the Fontan circuit. These changes are primarily progressive and consequently
lead to failure of the Fontan circuit. Late after the Fontan procedure, systolic
dysfunction becomes apparent. Administration of angiotensin converting enzyme
inhibitors or β-blockades may be beneficial for particular patients, although the
clinical evidence and cellular mechanisms remain to be elucidated.
6.4.4 Hepatic Dysfunction
Hepatic dysfunction, liver fibrosis, and cirrhosis are common complication of
patients long after Fontan operation. Recently, cases with hepatocellular carcinoma
after Fontan operation have been reported [19, 20]. Careful observation should be
necessary to detect the hepatic changes long after Fontan operation.
6.4.5 Management of Failing Fontan Patients
Patients who underwent atrio-pulmonary connection or lateral tunnel procedure are
likely to be complicated with thromboembolism or intractable arrhythmias due to
enlargement of the right atrium [14]. Surgical intervention with conversion to
TCPC is required before such complications become irreversible. Cardiac trans-
plantation may be the only option for patients with severe heart failure, intractable
arrhythmias, or recurrent PLE.
6.5 Future Direction and Clinical Implications
In the basic science field, embryonic development of left-right asymmetry has been
uncovered by means of mouse genetic engineering. In addition, advanced human
genetics have uncovered many responsible genes for heterotaxy syndrome. By
means of innovative technologies such as whole genome sequencing or patient-
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based human inducible pluripotent stem cells, novel genes will be clarified and
analyzed. In the clinical field, anatomical and physiological diagnosis from the fetal
period, better clinical managements after birth, and tailor-made surgical operations
will improve the prognosis. Cell- or tissue-based regeneration therapies and a new
ventricular assist device could improve cardiac function of failing Fontan patients.
Multiple approaches including basic and clinical science are necessary to improve
the prognosis and quality of life of heterotaxy patients.
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